drugset / Trial / NCT01018875
Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Efficacy and safety study of ABT-288 in adults with mild-to-moderate Alzheimer's disease.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-02
- Completion
- 2011-02
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-288 | Small molecule | — | — |
| Comparator | Donepezil | Small molecule | — | — |